| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | NuCare Pharmaceuticals, Inc. | 20260420 | 1 |
| These highlights do not include all the information needed to use SYMTUZA safely and effectively. See full prescribing information for SYMTUZA. SYMTUZA ® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Janssen Products LP | AMPAC Fine Chemicals | Gilead Alberta ULC | Patheon, Inc. | Evonik Operations GmbH | Janssen Pharmaceutica NV | Union Quimico Farmaceutica SA (Uquifa) | Janssen Cilag SpA | Esteve Quimica, SA | Yuhan Chemical, Inc. | Janssen Ortho LLC | Janssen Pharmaceuticals, Inc. | Janssen Pharmaceutical Sciences Unlimited Company | Porton Pharma Solutions Ltd | Thermo Fisher Scientific Cork Limited | 20260417 | 23 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | Gilead Sciences, Inc. | 20260330 | 24 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Bryant Ranch Prepack | 20260310 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20260305 | 1 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. GILEAD ACCESS PROGRAM VIREAD™ (tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2001 | Gilead Sciences, Inc. | 20260213 | 11 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Proficient Rx LP | 20260201 | 1 |
| TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | AvKARE | 20260115 | 5 |
| Tenofovir Disoproxil Fumarate Tablets Rx only These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval Date: 2001 | AvPAK | 20260109 | 4 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Strides Pharma Science Limited | Strides Pharma Global Pte. Ltd. | 20260108 | 10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Major Pharmaceuticals | 20251224 | 6 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Redpharm Drug | 20251213 | 2 |
| These highlights do not include all the information needed to use ODEFSEY safely and effectively. See full prescribing information for ODEFSEY. ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2016 | Gilead Sciences, Inc. | 20251202 | 13 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Bryant Ranch Prepack | 20251104 | 100 |
| These highlights do not include all the information needed to use DELSTRIGO safely and effectively. See full prescribing information for DELSTRIGO. DELSTRIGO ® (doravirine, lamivudine, and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Merck Sharp & Dohme LLC | 20251029 | 23 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | A-S Medication Solutions | 20251017 | 1 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | PD-Rx Pharmaceuticals, Inc. | 20251009 | 4 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Bryant Ranch Prepack | 20250929 | 102 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20250820 | 8 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20250728 | 3 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Major Pharmaceuticals | 20250718 | 6 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2011 | Gilead Sciences, Inc. | 20250716 | 21 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2011 | Gilead Sciences, Inc. | 20250716 | 10 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Gilead Sciences, Inc | 20250716 | 32 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2004 | Gilead Sciences, Inc | 20250716 | 12 |
| These highlights do not include all the information needed to use VEMLIDY safely and effectively. See full prescribing information for VEMLIDY. VEMLIDY ® (tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Gilead Sciences, Inc. | 20250714 | 17 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. Initial U.S. Approval: 2004 | AvKARE | 20250701 | 1 |
| These highlights do not include all the information needed to use DESCOVY safely and effectively. See full prescribing information for DESCOVY. DESCOVY ® (emtricitabine and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Gilead Sciences, Inc. | 20250620 | 12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | NuCare Pharmaceuticals, Inc. | 20250418 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 20250414 | 3 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Macleods Pharmaceuticals Limited | 20250303 | 9 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 2001 | Gilead Sciences, Inc. | 20250218 | 31 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Florida Pharmaceutical Products, LLC. | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 20250211 | 1 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Gilead Sciences, Inc. | 20250204 | 22 |
| These highlights do not include all the information needed to use GENVOYA safely and effectively. See full prescribing information for GENVOYA. GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2015 | Gilead Sciences, Inc. | 20250203 | 22 |
| Emtricitabine/TDF | Direct_Rx | 20250122 | 4 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | DirectRx | 20250121 | 2 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Quinn Pharmaceuticals | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 20250110 | 12 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | NuCare Pharmaceuticals, Inc. | 20241226 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE, RILPIVIRINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2011 | Mylan Pharmaceuticals Inc. | 20241214 | 1 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | Strides Pharma Science Limited | 20241212 | 6 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Cipla USA Inc. | CIPLA LIMITED KURKUMBH | APPCO PHARMA LLC | 20241205 | 4 |
| Emtricitabine and Tenofovir Disoproxil Fumarate Tablets | Zydus Lifesciences Limited | 20241128 | 6 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Proficient Rx LP | 20241001 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Teva Pharmaceuticals USA, Inc. | 20240930 | 15 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets | RedPharm Drug, Inc. | RedPharm Drug | 20240807 | 6 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Redpharm Drug, Inc. | LUPIN LIMITED | 20240807 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR Disoproxil Fumarate Tablets, for oral use Initial U.S. Approval: 2004 | Redpharm Drug, Inc. | 20240807 | 2 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | A-S Medication Solutions | 20240805 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Redpharm Drug | 20240724 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Redpharm Drug, Inc. | Zydus Pharmaceuticals USA Inc. | 20240718 | 2 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | NuCare Pharmaceuticals,Inc. | 20240716 | 5 |
| 4f4268c2-42aa-49fa-e054-00144ff88e88 | RedPharm Drug, Inc. | 20240715 | 4 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | QUALLENT PHARMACEUTICALS HEALTH LLC | Aurobindo Pharma Limited | 20240609 | 3 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | 20240609 | 6 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Aurobindo Pharma Limited | 20240607 | 18 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Teva Pharmaceuticals USA, Inc. | 20240528 | 7 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | A-S Medication Solutions | 20240516 | 4 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 20240510 | 8 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20240507 | 2 |
| These highlights do not include all the information needed to use BIKTARVY safely and effectively. See full prescribing information for BIKTARVY. BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2018 | A-S Medication Solutions | 20240430 | 5 |
| EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Golden State Medical Supply, Inc. | 20240408 | 7 |
| These highlights do not include all the information needed to use EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets 200 mg/300 mg, for oral use Initial U.S. Approval: 2004 | Strides Pharma Inc. | 20240318 | 3 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Cipla USA Inc. | CIPLA LIMITED GOA | CIPLA LIMITED KURKUMBH | 20240306 | 10 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Aurobindo Pharma Limited | 20240103 | 2 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Aurobindo Pharma Limited | 20231228 | 5 |
| These highlights do not include all the information needed to use EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2018 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20231115 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 20231102 | 11 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Bryant Ranch Prepack | 20230811 | 100 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | RPK Pharmaceuticals, Inc. | 20230810 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Macleods Pharmaceuticals Limited | 20230525 | 5 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit III | 20230126 | 4 |
| TENOFOVIR DISOPROXIL FUMARATE TABLETS These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Chartwell RX, LLC. | Chartwell Pharmaceuticals Congers, LLC | 20221212 | 2 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Qilu Pharmaceutical Co., Ltd. | Shandong Anhong Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. (High Tech Zone Site) | 20221027 | 11 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Camber Pharmaceuticals, Inc. | Annora Pharma Private Limited | 20220728 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | NorthStar RxLLC | Macleods Pharmaceuticals Limited | 20220725 | 2 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2004 | A-S Medication Solutions | 20220428 | 1 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EFAVIRENZ, EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Macleods Pharmaceuticals Limited | 20210918 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Amneal Pharmaceuticals NY LLC | 20210828 | 11 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | A-S Medication Solutions | 20210615 | 12 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | DIRECT RX | 20210601 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Exelan Pharmaceuticals, Inc. | appco-pharma-llc | 20210406 | 2 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Exelan Pharmaceuticals, Inc. | Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada | 20210312 | 1 |
| These highlights do not include all the information needed to use EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET safely and effectively. See full prescribing information for EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE TABLET. EFAVIRENZ, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2006 | Cipla USA Inc. | Cipla Patalganga | Genvion Corporation 500 Camiel Sys Street, Winnipeg, Manitoba R2J 4K2, Canada | 20210311 | 3 |
| These highlights do not include all the information needed to use CIMDUO safely and effectively. See full prescribing information for CIMDUO . CIMDUO ® (lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Viatris Specialty LLC | 20210215 | 5 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Cipla USA Inc. | Cipla Patalganga | Cipla Kurkumbh | 20210119 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 20201129 | 9 |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | Direct Rx | 20201119 | 1 |
| These highlights do not include all the information needed to use EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS. EMTRICITABINE and TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2004 | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited Oral Solid Dosage Unit | 20200720 | 3 |
| These highlights do not include all the information needed to use SYMFI safely and effectively. See full prescribing information for SYMFI . SYMFI ® (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2018 | Viatris Specialty LLC | 20191015 | 6 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval Date: 2001 | DOH CENTRAL PHARMACY | 20190124 | 1 |
| HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | NorthStar RxLLC | Hetero Labs Limited Unit III | 20181211 | 1 |
| These highlights do not include all the information needed to use TENOFOVIR DISOPROXIL FUMARATE TABLETS safely and effectively. See full prescribing information for TENOFOVIR DISOPROXIL FUMARATE TABLETS. TENOFOVIR DISOPROXIL FUMARATE tablets, for oral use Initial U.S. Approval: 2001 | Laurus Labs Limited | Laurus Labs Limited (VSP2) | 20180226 | 1 |
| These highlights do not include all the information needed to use ODEFSEY safely and effectively. See full prescribing information for ODEFSEY. ODEFSEY ® (emtricitabine, rilpivirine, and tenofovir alafenamide) tablets, for oral use Initial U.S. Approval: 2016 | A-S Medication Solutions | 20180110 | 4 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | Avera McKennan Hospital | 20170320 | 1 |
| These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets Initial U.S. Approval: 2006 | DOH CENTRAL PHARMACY | 20170123 | 3 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Avera McKennan Hospital | 20151125 | 1 |
| These highlights do not include all the information needed to use VIREAD safely and effectively. See full prescribing information for VIREAD. VIREAD ® (tenofovir disoproxil fumarate) tablets, for oral use VIREAD ® (tenofovir disoproxil fumarate) powder, for oral use Initial U.S. Approval: 2001 | Avera McKennan Hospital | 20151124 | 1 |
| These highlights do not include all the information needed to use Tenofovir disoproxil Fumarate Tablets safely and effectively. See full prescribing information for tenofovir disoproxil fumarate tablets. Tenofovir disoproxil fumarate tablets, for oral use Initial U.S. Approval: 2001 | AIZANT DRUG RESEARCH SOLUTIONS PVT LTD | 20150820 | 1 |
| These highlights do not include all the information needed to use STRIBILD safely and effectively. See full prescribing information for STRIBILD. STRIBILD ® (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2012 | State of Florida DOH Central Pharmacy | 20140306 | 1 |
| These highlights do not include all the information needed to use ATRIPLA safely and effectively. See full prescribing information for ATRIPLA. ATRIPLA ® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2006 | Physicians Total Care, Inc. | 20130503 | 3 |
| These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA ® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2011 | Physicians Total Care, Inc. | 20130315 | 1 |
| These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA ® (emtricitabine/tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004 | Physicians Total Care, Inc. | 20130301 | 2 |